|
The result was announced on Saturday, 6 February 2016.
Meanwhile, the S&P BSE Sensex was up 4.63 points or 0.02% at 24,621.60
On BSE, so far 11,972 shares were traded in the counter as against average daily volume of 5,751 shares in the past one quarter. The stock hit a high of Rs 1,245.75 and a low of Rs 1,181 so far during the day. The stock had hit a 52-week low of Rs 796.05 on 27 February 2015. The stock had hit a 52-week high of Rs 1,348 on 12 January 2016. The stock had underperformed the market over the past one month till 5 February 2016, sliding 6.06% compared with 3.77% decline in the Sensex. The scrip, however, outperformed the market in past one quarter, falling 0.09% as against Sensex's 6.41% fall.
The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.
AstraZeneca Pharma India's net sales rose 33.7% to Rs 144.56 crore in Q3 December 2015 over Q3 December 2014.
AstraZeneca Pharma India is present in seven crucial areas of healthcare - Cardiovascular, Diabetes, Oncology, Respiratory & Inflammation, Infection, Local Anesthesia and Maternal Healthcare.
|